Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance

27Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Various epidemiological studies, including case reports and -series in addition to larger, population-based studies, have reported an increased prevalence of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma in individuals with a prior history of immune-related conditions. This is believed to support the role of chronic antigen stimulation in the pathogenesis of these conditions. In this short review, we summarize some of the largest population-based studies researching autoimmune diseases, infections, and the subsequent risk of MGUS, and discuss our understanding on its etiology and pathogenesis. Furthermore, we highlight important methodological limitations of previous studies in the field, but almost all studies on MGUS have been based on clinical, possibly biased, cohorts. Finally, we discuss future directions in researching the associations of MGUS and other disorders, including immune-related conditions, where screening studies play an important role.

Cite

CITATION STYLE

APA

Sigurbergsdóttir, A. Ý., Love, T. J., & Kristinsson, S. Y. (2022, April 28). Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2022.876271

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free